Advertisement

Advertisement

HotelsFoodShoppingCoffeeGroceryGas

Opencell Technologies, Inc

Website

Advertisement

Advertisement

4320 Forest Park Ave Ste 303
Saint Louis, MO 63108
http://opencelltech.com

Opencell Technologies, Inc is a technology company based in Saint Louis, MO, specializing in developing innovative software solutions for businesses.

With a focus on cutting-edge technology and a commitment to quality, Opencell Technologies, Inc provides tailored software services to help companies streamline their operations and enhance their digital presence.

Generated from their business information

Also at this address

Cortex

Clinical Cytogenetics Laboratory

Innovate St Louis

Corliss, Meagan

Own this business?
Claim it
See a problem?

You might also like

Tetraimaging LLC

Tetraimaging LLC is a cutting-edge imaging company based in Saint Louis, MO, specializing in advanced technology solutions for various industries. With a focus on innovation and precision, Tetraimaging LLC offers a range of imaging services designed to meet the unique needs of its clients. Generated from their business information
Drugs affecting neoplasms and endrocrine systems

Immunophotonics, Inc.

Immunophotonics, Inc. is a pioneering biotechnology company based in Saint Louis, MO, dedicated to unlocking the potential of the immune system through the development of a new class of therapeutics. Their proprietary glycan polymer technology stimulates antigen capture and uptake, triggering an immune response that enables the rejection of cancer and other diseases. With practical applications in interventional oncology, immunotherapy, and vaccine enhancement, Immunophotonics aims to elevate modern medicine and improve outcomes for patients worldwide. Through their innovative approach, Immunophotonics is transforming conventional surgical interventions into systemically active immunotherapies, upregulating T-cell activation, downregulating T-cell exhaustion, and driving stronger immune responses. Their powerful immunoadjuvant, IP-001, has the potential to enhance antigen-specific immunity against infectious diseases, including SARS-CoV-2, and increase the efficacy of vaccines. Committed to global human health, Immunophotonics is at the forefront of advancing medical treatments and improving patient outcomes.Generated from the website
Blood derivatives

Accuronix Therapeutics Inc

Accuronix Therapeutics Inc is a cutting-edge biotechnology company based in St. Louis, MO, dedicated to developing innovative cancer therapies. Utilizing a unique drug-targeting technology, the company focuses on addressing the most challenging issues in cancer treatment, with an initial emphasis on pancreatic cancer. With strategic partnerships with renowned institutions like Washington University and the University of Pennsylvania, Accuronix Therapeutics aims to develop groundbreaking oncology therapies that selectively target -2 receptors, which are known to be overexpressed on cancer cells. Led by President and CEO Bradley T. Keller, Ph.D., the company is committed to pushing the boundaries of cancer therapy and making a significant impact in the field of oncology.Generated from the website
United States›Missouri›Saint Louis›Opencell Technologies, Inc

Partial Data by Infogroup (c) 2024. All rights reserved.

Advertisement

Advertisement

  • Get directions
  • MapQuest Travel
  • Route Planner
  • Print your map
  • Get help
  • Search the web
  • Send feedback
Learn more about our mobile apps.
  • Android app Google Play
  • Download on the App Store
  • Download on the Amazon Appstore
  • Enterprise solutions
  • Claim your business
  • Developer resources
  • Jobs
  • Advertise with us
  • Terms of use
  • Privacy policy
  • Data and licenses
  • About our ads
  • Do not sell